CRLF2 inhibitors (Southeast TechInventures)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCRLF2 inhibitors (Southeast TechInventures)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokine receptor-like factor 2 antagonists
TargetsCytokine receptor-like factor 2
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSoutheast TechInventures Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSoutheast TechInventures Inc
Active IndicationsN/A
Inactive IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A